ArticleLeukemia2008
Enhanced BCR-ABL kinase inhibition does not result in increased inhibition of downstream signaling pathways or increased growth suppression in CML progenitors.
H Konig et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
60 papers cite it
this papertrialcites it